A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate whether, after two 8-week treatment
periods, male patients with erectile dysfunction (ED) in China prefer 20 milligram (mg)
tadalafil or 100 mg sildenafil. This trial consists of two treatment periods of 8 weeks each
and an extension phase of 8 weeks, for a total of 24 weeks.